2026 Humana Basic Rx Plan (PDP) formulary (drug list)
Contract S5884, plan 108 · Louisiana · 2,972 drugs on file · formulary ID 00026399. Each drug links to its cost in every CMS PDP Region 21 plan.
28 drugs starting with K.
| Drug name | Tier | 30-day preferred pharmacy | 90-day mail order | Usage management |
|---|---|---|---|---|
| KALETRA 80/20 mg/mL SolutionLopinavir And Ritonavir | 5Specialty Tier | 25% | N/A | None |
| KARIVA KitDesogestrel/Ethinyl Estradiol And Ethinyl Estradiol | 3Preferred Brand | 25% | 20% | None |
| KELNOR 1/35 KitEthynodiol Diacetate And Ethinyl Estradiol | 3Preferred Brand | 25% | 20% | None |
| KERENDIA 10 mg Tablet, Film CoatedFinerenone | 3Preferred Brand | 25% | 20% |
|
| KERENDIA 20 mg Tablet, Film CoatedFinerenone | 3Preferred Brand | 25% | 20% |
|
| KERENDIA 40 mg TabletFinerenone | 3Preferred Brand | 25% | 20% |
|
| KETOCONAZOLE 20 mg/g CreamKetoconazole Cream, 2% | 3Preferred Brand | 25% | 20% |
|
| KETOCONAZOLE 20 mg/mL Shampoo, Suspension | 2Generic | $1.00 | $0.00 |
|
| KETOCONAZOLE 200 mg Tablet | 4Non-Preferred Drug | 32% | N/A |
|
| KETOROLAC TROMETHAMINE 10 mg Tablet, Film Coated | 4Non-Preferred Drug | 32% | N/A |
|
| KETOROLAC TROMETHAMINE 4 mg/mL Solution/ Drops | 3Preferred Brand | 25% | 20% |
|
| KETOROLAC TROMETHAMINE 5 mg/mL Solution | 3Preferred Brand | 25% | 20% |
|
| KINRIX 25/10/25/8/25/40/8/32 [iU]/.5mL/ug/.5mL Injection, SuspensionDiphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed And Inactivated Poliovirus Vaccine | 1Preferred Generic | $0.00 | $0.00 | None |
| KISQALI 200 mg Tablet, Film CoatedRibociclib | 5Specialty Tier | 25% | N/A |
|
| KISQALI 200 mg Tablet, Film CoatedRibociclib | 5Specialty Tier | 25% | N/A |
|
| KISQALI 200 mg Tablet, Film CoatedRibociclib | 5Specialty Tier | 25% | N/A |
|
| KLOR-CON 600 mg Tablet, Film Coated, Extended ReleasePotassium Chloride | 2Generic | $1.00 | $0.00 | None |
| KLOR-CON 750 mg Tablet, Film Coated, Extended ReleasePotassium Chloride | 2Generic | $1.00 | $0.00 | None |
| KLOR-CON M 1125 mg Tablet, Extended ReleasePotassium Chloride | 2Generic | $1.00 | $0.00 | None |
| KLOR-CON M 1500 mg Tablet, Extended ReleasePotassium Chloride | 2Generic | $1.00 | $0.00 | None |
| KLOR-CON M 750 mg Tablet, Extended ReleasePotassium Chloride | 2Generic | $1.00 | $0.00 | None |
| KLOXXADO 8 mg/.1mL SprayNaloxone Hcl | 3Preferred Brand | 25% | 20% | None |
| KOSELUGO 10 mg CapsuleSelumetinib | 5Specialty Tier | 25% | N/A |
|
| KOSELUGO 25 mg CapsuleSelumetinib | 5Specialty Tier | 25% | N/A |
|
| KOSELUGO 5 mg GranuleSelumetinib | 5Specialty Tier | 25% | N/A |
|
| KOSELUGO 7.5 mg GranuleSelumetinib | 5Specialty Tier | 25% | N/A |
|
| KRAZATI 200 mg Tablet, CoatedAdagrasib | 5Specialty Tier | 25% | N/A |
|
| KURVELO KitLevonorgestrel And Ethinyl Estradiol | 3Preferred Brand | 25% | 20% | None |
PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.